Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arlene Hurley

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Journal of Virology|March 29, 2003
A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivoMartin Markowitz, Michael Louie, Arlene Hurley, et al.
AIDS (London, England)|July 20, 2002
Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individualsViviana Simon, Jeroen Vanderhoeven, Arlene Hurley, et al.
Journal of Virology|October 29, 2003
Viral blip dynamics during highly active antiretroviral therapyMichele Di Mascio, Martin Markowitz, Michael Louie, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2022
Temporal relations between peripheral and central arousals in good and poor sleepersAna Ribeiro, Rachel Gabriel, Bernardo Garcia, et al.
The Journal of Experimental Medicine|September 15, 2004
Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tractSaurabh Mehandru, Michael A Poles, Klara Tenner-Racz, et al.
Journal of Virology|September 16, 2004
Dynamics of intermittent viremia during highly active antiretroviral therapy in patients who initiate therapy during chronic versus acute and early human immunodeficiency virus type 1 infectionMichele Di Mascio, Martin Markowitz, Michael Louie, et al.
Biorxiv : the Preprint Server for Biology|December 17, 2020
Persistent Cellular Immunity to SARS-CoV-2 InfectionGaëlle Breton, Pilar Mendoza, Thomas Hagglof, et al.
The Journal of Experimental Medicine|February 3, 2021
Persistent cellular immunity to SARS-CoV-2 infectionGaëlle Breton, Pilar Mendoza, Thomas Hägglöf, et al.
Journal of Virology|November 27, 2004
Neutralization profiles of newly transmitted human immunodeficiency virus type 1 by monoclonal antibodies 2G12, 2F5, and 4E10Saurabh Mehandru, Terri Wrin, Justin Galovich, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2004
Intensification of antiretroviral therapy accelerates the decay of the HIV-1 latent reservoir and decreases, but does not eliminate, ongoing virus replicationBharat Ramratnam, Ruy Ribeiro, Tian He, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Journal of Virology|March 29, 2003
A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivoMartin Markowitz, Michael Louie, Arlene Hurley, et al.
AIDS (London, England)|July 20, 2002
Evolving patterns of HIV-1 resistance to antiretroviral agents in newly infected individualsViviana Simon, Jeroen Vanderhoeven, Arlene Hurley, et al.
Journal of Virology|October 29, 2003
Viral blip dynamics during highly active antiretroviral therapyMichele Di Mascio, Martin Markowitz, Michael Louie, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2022
Temporal relations between peripheral and central arousals in good and poor sleepersAna Ribeiro, Rachel Gabriel, Bernardo Garcia, et al.
The Journal of Experimental Medicine|September 15, 2004
Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tractSaurabh Mehandru, Michael A Poles, Klara Tenner-Racz, et al.
Journal of Virology|September 16, 2004
Dynamics of intermittent viremia during highly active antiretroviral therapy in patients who initiate therapy during chronic versus acute and early human immunodeficiency virus type 1 infectionMichele Di Mascio, Martin Markowitz, Michael Louie, et al.
Biorxiv : the Preprint Server for Biology|December 17, 2020
Persistent Cellular Immunity to SARS-CoV-2 InfectionGaëlle Breton, Pilar Mendoza, Thomas Hagglof, et al.
The Journal of Experimental Medicine|February 3, 2021
Persistent cellular immunity to SARS-CoV-2 infectionGaëlle Breton, Pilar Mendoza, Thomas Hägglöf, et al.
Journal of Virology|November 27, 2004
Neutralization profiles of newly transmitted human immunodeficiency virus type 1 by monoclonal antibodies 2G12, 2F5, and 4E10Saurabh Mehandru, Terri Wrin, Justin Galovich, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2004
Intensification of antiretroviral therapy accelerates the decay of the HIV-1 latent reservoir and decreases, but does not eliminate, ongoing virus replicationBharat Ramratnam, Ruy Ribeiro, Tian He, et al.
Pageof 4